Services

BioPharmaceuticals, medical technology and generics

Insights and services

Deloitte’s life sciences specialists provide comprehensive, integrated solutions to the biopharmaceutical, medical technology and generics segments. Our dedicated industry practitioners work with companies in each of the segments to address the challenges and opportunities of the evolving health care ecosystem. Our breadth of services and industry knowledge allow us to understand each client’s unique business needs.

Medical technology

More on the segment:
Medical technology

​The $100+ billion medical technology (med tech) industry is experiencing changes – pricing pressure that could threaten the innovation pipeline; increasingly stringent regulatory requirements; new value-based care models that require new value propositions; globalization complexities that call for new insights; and a shifting customer landscape that is likely to influence the buying process. Now med tech companies need to reconfigure their strategies and business models to deliver differentiated value and performance. 

BioPharmaceuticals

More on the segment:
BioPharmaceuticals

The BioPharmaceutical marketplace is rapidly shifting and evolving. BioPharmaceutical organizations need to be nimble yet continue to grow revenue and market share even as industry dynamics propel increased focus on regulatory compliance, lower costs, innovation, and network flexibility.

Generics

More on the segment:
Generics

Generics companies operating in the broader BioPharmaceutical market are being challenged by powerful dynamics including regulatory reforms, the Affordable Care Act, globalization, and the convergence of the Health Care and Life Sciences industries.
 

Meet our leader

Homi Kapadia

Homi Kapadia

U.S. Life Sciences Sector Leader

Homi, the Vice Chairman of Deloitte LLP, has nearl...More

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Find an office

Find a local office

People

Matthew Hudes

Principal | U.S. Managing Principal, Biotechnology

People

Glenn Snyder

Medical Technology Segment Leader

People

Faith Glazier

Life Science Generics Segment Leader